Alcon Operating Income 2019-2025 | ALC
Alcon annual/quarterly operating income history and growth rate from 2019 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Alcon operating income for the quarter ending March 31, 2025 was $468M, a 27.17% increase year-over-year.
- Alcon operating income for the twelve months ending March 31, 2025 was $1.513B, a 32.84% increase year-over-year.
- Alcon annual operating income for 2024 was $1.413B, a 36% increase from 2023.
- Alcon annual operating income for 2023 was $1.039B, a 54.61% increase from 2022.
- Alcon annual operating income for 2022 was $0.672B, a 15.86% increase from 2021.
| Alcon Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $1,413 |
| 2023 | $1,039 |
| 2022 | $672 |
| 2021 | $580 |
| 2020 | $-482 |
| 2019 | $-187 |
| 2018 | $-248 |
| Alcon Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $468 |
| 2024-12-31 | $395 |
| 2024-09-30 | $332 |
| 2024-06-30 | $318 |
| 2024-03-31 | $368 |
| 2023-12-31 | $208 |
| 2023-09-30 | $293 |
| 2023-06-30 | $270 |
| 2023-03-31 | $268 |
| 2022-12-31 | $21 |
| 2022-09-30 | $205 |
| 2022-06-30 | $200 |
| 2022-03-31 | $246 |
| 2021-12-31 | $182 |
| 2021-09-30 | $20 |
| 2021-06-30 | $229 |
| 2021-03-31 | $149 |
| 2020-12-31 | $141 |
| 2020-09-30 | $-129 |
| 2020-06-30 | $-466 |
| 2020-03-31 | $-28 |
| 2019-12-31 | $-68 |
| 2019-09-30 | $-18 |
| 2019-06-30 | $-53 |
| 2019-03-31 | $-48 |
| 2018-12-31 | |
| 2018-09-30 | $-284 |
| 2018-06-30 | $38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.308B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.004B | 88.48 |
| Thermo Fisher Scientific (TMO) | United States | $155.550B | 18.82 |
| Edwards Lifesciences (EW) | United States | $45.755B | 30.00 |
| IDEXX Laboratories (IDXX) | United States | $41.667B | 47.88 |
| DexCom (DXCM) | United States | $33.517B | 51.81 |
| STERIS (STE) | Ireland | $24.719B | 27.26 |
| IQVIA Holdings (IQV) | United States | $24.708B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.055B | 28.61 |
| Waters (WAT) | United States | $21.392B | 30.18 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.121B | 0.00 |
| Hologic (HOLX) | United States | $12.655B | 13.75 |
| Penumbra (PEN) | United States | $10.870B | 85.31 |
| Sysmex ADR (SSMXY) | Japan | $10.657B | 30.23 |
| Masimo (MASI) | United States | $8.438B | 31.12 |
| Globus Medical (GMED) | United States | $8.424B | 19.76 |
| Teleflex (TFX) | United States | $5.713B | 9.43 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.112B | 89.40 |
| PROCEPT BioRobotics (PRCT) | United States | $3.213B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.421B | 14.42 |
| Veracyte (VCYT) | United States | $2.287B | 32.09 |
| Nihon Kohden (NHNKY) | Japan | $2.213B | 25.38 |
| Elekta AB (EKTAY) | Sweden | $2.048B | 18.41 |
| Alphatec Holdings (ATEC) | United States | $1.894B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.537B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 118.04 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.055B | 5.61 |
| SiBone (SIBN) | United States | $0.843B | 0.00 |
| IRadimed (IRMD) | United States | $0.685B | 34.78 |
| Mesa Laboratories (MLAB) | United States | $0.665B | 14.54 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.43 |
| Delcath Systems (DCTH) | United States | $0.596B | 0.00 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| NeuroPace (NPCE) | United States | $0.574B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.560B | 0.00 |
| AxoGen (AXGN) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.474B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.456B | 12.13 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.311B | 0.00 |
| Neuronetics (STIM) | United States | $0.278B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.184B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.165B | 0.00 |
| 908 Devices (MASS) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.164B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.141B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.125B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 44.60 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |